[Treatment of hyperthyroidism: inhibitors of T4-T3 conversion].
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000638:Amiodarone / Q000494:pharmacology; D013956:Antithyroid Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy / Q000378:metabolism*; D007487:Ipodate / Q000494:pharmacology; D008094:Lithium / Q000494:pharmacology; D008713:Methimazole / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011441:Propylthiouracil / Q000494:pharmacology; D013974:Thyroxine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D014284:Triiodothyronine / Q000378:metabolism*
D000305:Adrenal Cortex Hormones; D013956:Antithyroid Agents; D014284:Triiodothyronine; D008713:Methimazole; D011441:Propylthiouracil; D008094:Lithium; D011433:Propranolol; D007487:Ipodate; D000638:Amiodarone; D013974:Thyroxine
Le traitement des hyperthyroïdies: les inhibiteurs de la conversion de T4 en T3.